Publication | Closed Access

Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillation

CardiomyopathyHeart FailureCardiac AnaesthesiaCardiovascular DiseasePharmacologyCardiovascular PharmacologySafety OfdigoxinLow-dosediltiazem OrbetaxololPharmacotherapyAtrial FibrillationPublic HealthMedicineCardiologyChronic Atrial FibrillationDiastolic Function